Welcome to International Society for Vaccines
Professor Hill serves as the Founding Director of the Jenner Institute and Chairman of the Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford; is a Fellow of Magdalen College, Oxford, a Fellow of the Royal College of Physicians, and a Fellow of the Academy of Medical Sciences. Professor Hill holds an academic appointment as Professor of Human Genetics at the Wellcome Centre for Human Genetics at the University of Oxford, which studies genetic susceptibility factors for common bacterial diseases. He the leader of one of the most successful translational research programs in the UK, with over 25 new vaccines designed, manufactured, and assessed in clinical trials.
Professor Hill focused his research on the development of a range of viral vectored vaccination approaches, which are currently in widespread clinical development. His research has also focused on the discovery of approaches that induce cellular immunity in humans (prime-boost and prime-target vaccination) leading to clinical development in multiple infectious disease and cancer indications for both disease prevention and immunotherapy,
Dr. Hill has served as Chief Investigator on over 50 clinical trials, including clinical trials for malaria vaccines and the first clinical trial of a monovalent Ebola virus vaccine (cAd3-ZEBOV) aimed at targeting the West African Ebola virus epidemic. Prof. Hill has been an active participant in the ISV Congresses, including being on the Scientific committee in 2016 and 2017, and as a plenary speaker. He is particularly interested in guiding the scientific program efforts for both future Congresses and regional topical ISV meetings, ensuring that the meetings have an important emphasis on diseases primarily affecting developing countries including One Health programs and is passionate about extending pre-clinical vaccinology research to more centers in sub-Saharan Africa.